MedPath

The Effect of a Botanical Plant Extract on Gut Health, Immunity and Metabolic Disorders in Healthy Adults

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: Middle dose response efficacy of plant extracts
Dietary Supplement: High Dose response efficacy of plant extracts
Dietary Supplement: Low dose response efficacy of plant extracts
Dietary Supplement: Placebo
Registration Number
NCT03921333
Lead Sponsor
University of Roehampton
Brief Summary

There is an enormous increase in diabetes mellitus worldwide, especially in developed countries. Ninety percent of diabetes cases worldwide are of Type II diabetes mellitus (T2DM) as a result of greater prevalence of sedentary lifestyle, unhealthy diet and rise of obesity, as well as an increasing number of elderly populations. T2DM can be attributed to relative deficiency of insulin involving insulin resistance, aberrant synthesis of hepatic glucose and progressive deterioration of pancreatic beta-cell functions resulting in chronic hyperglycaemia. A growing amount of evidence has emerged in the last several years linking various nutrients and food sources with a positive management of T2DM. In in vitro studies, various botanical extracts have been found to significantly inhibit the activity of alpha-glucosidase and alpha-amylase. The inhibition of these enzymes' activity is a rational approach in managing glucose level for borderline and T2DM sufferers as inhibition of both alpha-amylase and alpha-glucosidase activity can profoundly reduce post-prandial increase in blood plasma glucose concentration following a mixed carbohydrate intake. Excessive levels of blood plasma glucose and free fatty acids impose a stressful condition for pancreatic beta-cells and other insulin sensitive cells resulting in the local secretion of pro-inflammatory cytokines and chemokines causing a continuous low levels of abnormal inflammation that alter insulin's action. As the body becomes less sensitive to insulin, the resulting insulin resistance leads to further inflammation, with more inflammation causing more insulin resistance, causing blood plasma sugar levels to continuously increase, eventually resulting in T2DM. In in vitro animal models, various compounds of botanical origin have also been shown to possess anti-inflammatory activities which can be beneficial in managing T2DM.

Detailed Description

The aim of this human intervention study is to evaluate the impact of a botanical-based extract on gut health, immunity and metabolic disorders in healthy adults.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Middle dose plant extractMiddle dose response efficacy of plant extracts500 mg
High Dose plant extractHigh Dose response efficacy of plant extracts700 mg
Low dose plant extractLow dose response efficacy of plant extracts300 mg
Placebo controlPlaceboCellulose microcrystalline
Primary Outcome Measures
NameTimeMethod
Monitoring Blood pressure changesChanges from baseline to 4 and 8 week treatment period with plant extracts

mm/Hg

Microbiota compositionChanges from baseline to 4 and 8 week treatment period with plant extracts

DNA profiling from faeces (bacteria numbers/g faeces)

Body weight MeasurementsChanges from baseline to 4 and 8 week treatment period with plant extracts

Weight in kilograms

Modulation of blood lipidsChanges from baseline to 4 and 8 week treatment period with plant extracts

Effects on TC, LDL-C, HDL-C and TAG expressed in mmol/L

Changes in insulinChanges from baseline to 4 and 8 week treatment period with plant extracts

Effect of insulin levels expressed in mg/dl

Body mass Index measurementsChanges from baseline to 4 and 8 week treatment period with plant extracts

kg/m\^2

Modulation of immune function by plant extractsChanges from baseline to 4 and 8 week treatment period with plant extracts

Cytokines analysis on IL6,IL10, IL2 and TNFa expressed in pg/mL

Secondary Outcome Measures
NameTimeMethod
Dietary assessmentChanges from baseline to 4 and 8 week treatment period with plant extracts

Food Dietary intake analysis via DietPlan 7

Trial Locations

Locations (1)

Health Sciences Research Centre, Life Sciences Department, University of Roehampton

🇬🇧

London, UK, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath